CLDXPASS
Celdex therapies
Barzolvolimab
-21.2%
Return
Bought
$39.46
2026-09-02
Sold
$31.08
2026-09-22
-21.2% from 09/02 to 09/22
Topline: September 22, 2026
Completed Picks
Closed Position Performance
Track each position from its entry date to the recorded exit date.
Portfolio ledger
Lifetime Performance
Portfolio return
+81.7%
Across closed positions
Closed positions
14
Completed entry-to-exit trades
Clinical outcomes
9 pass · 5 fail
64% pass rate
Round 4 Picks
1 Completed
Round 3 Picks
2 Completed
HCMPASS
HUTCHMED (China) Limited
ORPATHYS (savolitinib) and TAGRISSO (osimertinib) - (SANOVO)
-4.1%
Return
Bought
$12.56
2026-05-15
Sold
$12.04
2026-09-03
-4.1% from 05/15 to 09/03
Topline: September 1, 2026
AVBPFAIL
ArriVent BioPharma
Furmonertinib - (FURVENT)
-47.9%
Return
Bought
$28.97
2026-05-13
Sold
$15.09
2026-10-06
-47.9% from 05/13 to 10/06
Topline: October 6, 2026
Round 2 Picks
5 Completed
ALMSPASS
Alumis Inc.
EryDex (intra-erythrocyte dexamethasone)
+161.5%
Return
Bought
$8.94
2026-01-02
Sold
$23.38
2026-04-09
+161.5% from 01/02 to 04/09
Topline: March 30, 2026
ALMSPASS
Alumis Inc.
ESK-001
+93.1%
Return
Bought
$8.94
2026-01-02
Sold
$17.26
2026-01-06
+93.1% from 01/02 to 01/06
Topline: January 6, 2026
XENEPASS
Xenon Pharmaceuticals
Azetukalner (XEN1101)
+38.0%
Return
Bought
$44.49
2026-01-02
Sold
$61.39
2026-03-09
+38.0% from 01/02 to 03/09
Topline: March 9, 2026
CYTKPASS
Cytokinetics Incorporated
Aficamten (CY 601)
+26.4%
Return
Bought
$61.73
2026-01-02
Sold
$78.05
2026-05-05
+26.4% from 01/02 to 05/05
Topline: May 5, 2026
OCULFAIL
oculis
OCS-01 (dexamethasone ophthalmic)
-24.5%
Return
Bought
$11.82
2026-01-02
Sold
$8.93
2026-06-01
-24.5% from 01/02 to 06/01
Topline: May 28, 2026
Round 1 Picks
6 Completed
ABVXPASS
Abivax S.A.
Obefazimod - (ABTECT)
+721.4%
Return
Bought
$7.70
2025-06-29
Sold
$63.25
2025-07-23
+721.4% from 06/29 to 07/23
Topline: July 22, 2025
DBVTPASS
DBV Technologies
Viaskin Peanut - (VITESSE)
+99.3%
Return
Bought
$11.37
2025-06-29
Sold
$22.66
2025-12-17
+99.3% from 06/29 to 12/17
Topline: December 17, 2025
ABBVPASS
AbbVie
RINVOQ (upadacitinib)
+5.6%
Return
Bought
$183.00
2025-06-29
Sold
$193.22
2025-08-01
+5.6% from 06/29 to 08/01
Topline: July 30, 2025
ACADFAIL
Levo Therapeutics, Inc. (aquired by ACADIA Pharmaceuticals Inc)
Carbetocin (ACP-101) - (COMPASS PWS)
-2.7%
Return
Bought
$22.12
2025-06-29
Sold
$21.53
2025-09-24
-2.7% from 06/29 to 09/24
Topline: September 24, 2025
VTGNFAIL
Pherin Pharmaceuticals, Inc. acquired by Vistagen (Nasdaq: VTGN) i
PH94B - (PALISADE-4)
-61.1%
Return
Bought
$2.03
2025-06-29
Sold
$0.79
2025-12-17
-61.1% from 06/29 to 12/17
Topline: December 17, 2025
SNGXFAIL
Soligenix
HyBryte - (FLASH2)
-69.9%
Return
Bought
$1.36
2025-06-29
Sold
$0.41
2026-04-28
-69.9% from 06/29 to 04/28
Topline: April 28, 2026